Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia.
Tai
T S
TS
Sheu
W H
WH
Lee
W J
WJ
Yao
H T
HT
Chiang
M T
MT
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D002686:Chitin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D048271:Chitosan; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008074:Lipoproteins / Q000097:blood*; D010919:Placebos; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D008074:Lipoproteins; D010919:Placebos; D014280:Triglycerides; D002686:Chitin; D048271:Chitosan